*Keiichi Ishihara1, Eri Kawashita1, Kaneyau Nishimura2, Michiko Saito3, Haruhiko Sago4, Kazuhiro Yamakawa5, Satoshi Akiba1, Kazuyuki Takata2
(1. Dept of Pathol Biochem, Kyoto Pharm Univ, Kyoto, Japan, 2. Divi of Integ Pharm Sci, Kyoto Pharm Univ, Kyoto, Japan, 3. Bio-sci Res Centr, Kyoto Pharm Univ, Kyoto, Japan, 4. Centr for Maternal-Fetal, Neonat & Reproduct Med, Natl Centr for Child Health & Development, Tokyo, Japan, 5. Depart of Neurodevelop Dis Genet, Nagoya City Univ Grad Sch Med Sci, Aichi, Japan)
Keywords:Down syndrome, Alzheimer's disease
Abstract password authentication.
A password is required to view the full text of the abstract. Please enter the following password.
PW: Neuro2022